Publicaciones en las que colabora con MANUEL GUZMÁN PASTOR (59)

2018

  1. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

    Biochemical Pharmacology, Vol. 157, pp. 275-284

  2. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

    Biochemical Pharmacology, Vol. 157, pp. 266-274

2016

  1. Anticancer mechanisms of cannabinoids

    Current Oncology, Vol. 23, pp. S23-S32

  2. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization

    Autophagy, Vol. 12, Núm. 11, pp. 2213-2229

2015

  1. Endocannabinoids and cancer

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 449-472

  2. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144

  3. TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling

    Molecular and Cellular Oncology, Vol. 2, Núm. 3

2013

  1. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 10, pp. 1573-1578

2012

  1. Towards the use of cannabinoids as antitumour agents

    Nature Reviews Cancer, Vol. 12, Núm. 6, pp. 436-444

2011

  1. A combined preclinical therapy of cannabinoids and temozolomide against glioma

    Molecular Cancer Therapeutics, Vol. 10, Núm. 1, pp. 90-103

  2. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: Role of AMPK-dependent activation of autophagy

    Cell Death and Differentiation, Vol. 18, Núm. 7, pp. 1099-1111

  3. Detecting autophagy in response to ER stress signals in cancer

    Methods in Enzymology (Academic Press Inc.), pp. 297-317

  4. Erratum: Anti-tumoral action of cannabinoids on hepatocellular carcinoma: Role of AMPK-dependent activation of autophagy (Cell Death and Differentiation (2011) 18 (1099-1111) DOI:10.1038/cdd.2011.32)

    Cell Death and Differentiation

  5. Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death

    Autophagy, Vol. 7, Núm. 9, pp. 1071-1073

  6. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action

    Cell Death and Differentiation, Vol. 18, Núm. 6, pp. 959-973

  7. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2009

  1. Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis

    GLIA, Vol. 57, Núm. 13, pp. 1374-1385

  2. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells

    Journal of Clinical Investigation, Vol. 119, Núm. 5, pp. 1359-1372

  3. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma

    Molecular Cancer Therapeutics, Vol. 8, Núm. 7, pp. 1838-1845

  4. Cannabinoids as potential antitumoral agents in pancreatic cancer

    Pancreatology: From Bench to Bedside (Springer Berlin Heidelberg), pp. 39-49